NCT04184232已完成2 期
Treatment of Recurrent Bladder Cancer With Autologous Monocyte-derived Dendritic Cells
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus2 个研究点 分布在 1 个国家目标入组 17 人开始时间: 2019年7月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 17
- 试验地点
- 2
- 主要终点
- Efficacy evaluation
研究概览
简要总结
Treatment of recurrent bladder cancer with dendritic cells
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 85 Years（Adult, Older Adult）
- 性别
- Male
- 接受健康志愿者
- 否
入选标准
- •Histologically confirmed diagnosis of pTa bladder cancer;
- •Patient who require repetitive transurethral resection;
- •Expression of muc-1/wt-1 by the tumor;
- •EGOC 0-3;
排除标准
- •any medical condition which can be associated with the high risk for the patient;
- •pregnancy/lactation;
- •chronic infections, including hepatitis B/C, tuberculosis, HIV
结局指标
主要结局
Efficacy evaluation
时间窗: 1 year
1 year relapse free survival
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
A Study of Real-world Treatment of Adults With Urothelial Cancer in South Korea and Saudi ArabiaMetastatic Urothelial CancerNCT06505746Astellas Pharma Singapore Pte. Ltd.287
进行中（未招募）
2 期
CIK in Treating Patients With Bladder CancerUrinary Bladder NeoplasmsNCT02489890The First People's Hospital of Changzhou1,500
招募中
2 期
NEO-BLAST: Neoadjuvant Therapy for Bladder Cancer Followed by Active Surveillance vs TreatmentMuscle-Invasive Bladder CarcinomaNCT06537154Peter Black688
已完成
不适用
Follow-Up of Bladder Cancer Patients From the New England Study of Environment and HealthBladder CancerNCT00776178National Cancer Institute (NCI)68
招募中
不适用
To investigate whether rinsing the bladder with chemotherapy right before an operation that removes the kidney and ureter because of a malignant tumor is effective to reduce the risk of a subsequent bladder tumorNL-OMON24959Erasmus university Medical Center170